RAPIBLYK
- Product NDC
- 87073-110
- 11-digit product format
- 870730110
- Labeler code
- 87073
- Product ID
- 87073-110_4b8f0a9c-ab80-1c57-e063-6294a90a8f1b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- landiolol
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- AOP Health US, LLC
- Application
- NDA217202
- Marketing category
- NDA
- Marketing start
- 2025-05-19
- Substance
- LANDIOLOL HYDROCHLORIDE
- Active strength
- 280 mg/1
- Pharmacologic classes
- Adrenergic beta1-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- RAPIBLYK
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LANDIOLOL HYDROCHLORIDE | 280 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | G8HQ634Y17 |
| Rxcui | 2712074, 2712079 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 87073-110-01 | RAPIBLYK | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 6 |
| 87073-110-01 | RAPIBLYK | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | | 6 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 87073-110-01 | 87073011001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (87073-110-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE | 2025-05-19 | No | No | Historical |